Trypanosome resistance to human innate immunity: targeting Achilles' heel

被引:16
|
作者
Stephens, Natalie A. [1 ]
Kieft, Rudo [1 ]
MacLeod, Annette [2 ]
Hajduk, Stephen L. [1 ]
机构
[1] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA
[2] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Inst Biodivers Anim Hlth & Comparat Med, Coll Med Vet & Life Sci, Glasgow G61 1QH, Lanark, Scotland
基金
英国惠康基金;
关键词
African trypanosomes; innate immunity; high density lipoproteins; haptoglobin; apolipoprotein L-1; haptoglobin related protein; serum resistance associated protein; trypanosome lytic factor; HIGH-DENSITY-LIPOPROTEIN; VARIANT SURFACE GLYCOPROTEIN; HAPTOGLOBIN-RELATED PROTEIN; NORMAL HUMAN-SERUM; GAMBIENSE GROUP 1; LYTIC FACTOR; AFRICAN TRYPANOSOMES; BRUCEI-RHODESIENSE; TRYPANOLYTIC FACTOR; SCAVENGER RECEPTOR;
D O I
10.1016/j.pt.2012.09.002
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Trypanosome lytic factors (TLFs) are powerful, naturally occurring toxins in humans that provide sterile protection against infection by several African trypanosomes. These trypanocidal complexes predominantly enter the parasite by binding to the trypanosome haptoglobin/hemoglobin receptor (HpHbR), trafficking to the lysosome, causing membrane damage and, ultimately, cell lysis. Despite TLF-mediated immunity, the parasites that cause human African Trypanosomiasis (HAT), Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense, have developed independent mechanisms of resistance to TLF killing. In this review we describe the parasite defenses that allow trypanosome infections of humans and discuss how targeting these apparent strengths of the parasite may reveal their Achilles' heel, leading to new approaches in the treatment of HAT.
引用
收藏
页码:539 / 545
页数:7
相关论文
共 50 条
  • [31] Targeting an Achilles' heel of cancer with a WRN helicase inhibitor
    Aggarwal, Monika
    Banerjee, Taraswi
    Sommers, Joshua A.
    Brosh, Robert M., Jr.
    CELL CYCLE, 2013, 12 (20) : 3329 - 3335
  • [32] CBP/Catenin antagonists: Targeting LSCs' Achilles heel
    Kim, Yong-Mi
    Gang, Eun-Ji
    Kahn, Michael
    EXPERIMENTAL HEMATOLOGY, 2017, 52 : 1 - 11
  • [33] Activity of trypanosome lytic factor: a novel component of innate immunity
    Thomson, Russell
    Samanovic, Marie
    Raper, Jayne
    FUTURE MICROBIOLOGY, 2009, 4 (07) : 789 - 796
  • [34] INNATE IMMUNITY Targeting the messenger
    Minton, Kirsty
    NATURE REVIEWS IMMUNOLOGY, 2009, 9 (05) : 308 - 308
  • [35] Targeting ERK, an Achilles' Heel of the MAPK pathway, in cancer therapy
    Liu, Feifei
    Yang, Xiaotong
    Geng, Meiyu
    Huang, Min
    ACTA PHARMACEUTICA SINICA B, 2018, 8 (04) : 552 - 562
  • [36] Drug design targeting the main protease, the Achilles' heel of coronaviruses
    Yang, Haitao
    Bartlam, Mark
    Rao, Zihe
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (35) : 4573 - 4590
  • [37] Mycolic acids: deciphering and targeting the Achilles' heel of the tubercle bacillus
    Nataraj, Vijayashankar
    Varela, Cristian
    Javid, Asma
    Singh, Albel
    Besra, Gurdyal S.
    Bhatt, Apoorva
    MOLECULAR MICROBIOLOGY, 2015, 98 (01) : 7 - 16
  • [38] Finding Achilles heel of drug resistance in Mycobacterium tuberculosis
    Chandran, Nisha
    Sharma, Mukta
    Jainarayanan, Ashwin K.
    Brahmachari, Samir K.
    CURRENT SCIENCE, 2018, 114 (12): : 2430 - 2431
  • [39] Targeting ERK,an Achilles' Heel of the MAPK pathway,in cancer therapy
    Feifei Liu
    Xiaotong Yang
    Meiyu Geng
    Min Huang
    Acta Pharmaceutica Sinica B, 2018, 8 (04) : 552 - 562
  • [40] Cytoskeletal Remodelling as an Achilles' Heel for Therapy Resistance in Melanoma
    Barreno, Adrian
    Orgaz, Jose L.
    CELLS, 2022, 11 (03)